The company will pay $1.2bn in upfront and milestone fees to access Degron’s GlueXplorer platform across multiple therapeutic areas.

As Shanghai seeks to develop into an international biopharma hub, the local government is encouraging commercial medical insurers to cover more innovative drugs in their products. The policy aims to provide an alternative solution to dominant pricing by the national public payer, which often imposes deep discounts on novel drugs in exchange for reimbursement coverage.

Vagisil and BioFilm’s Astroglide “demonstrate very high levels of brand awareness, brand loyalty, and repeat purchase, and continue to attract new and younger consumers into the category,” firms say.

Women’s Voices for the Earth says Prestige Brands has “quietly reformulated” Summer’s Eve products to eliminate three colorants that should not be in feminine washes, based on FDA regulations and the realities of consumer practices and women’s anatomy. Now the NGO is considering next steps.